News
-
-
-
-
-
PRESS RELEASE
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
Dogwood Therapeutics announces presentation on Halneuron® pain management research program at Pain Therapeutics Summit. Developing non-opioid analgesics for cancer pain relief